Increased risk of myocardial infarction and arterial hypertension has been found in individuals who carry a functional variant of cytochrome P450 1A2 (CYP1A2), which makes them less effective in metabolizing caffeine [31–33]. This evidence concerns the gene CYP1A2 and myocardial infarction.